Aminomethyl-5 oxazolidinic derivatives and therapeutic use thereof
Patent 4476136 Issued on October 9, 1984. Estimated Expiration Date: 
February 24, 2002. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
February 24, 2002. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3654298 3687965 Novel 5-hydroxymethyl oxazolidinones, the method of preparing them and their application in therapeutics N-Aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones Patent #: 4348393 InventorsAssigneeApplicationNo. 06/351888 filed on 02/24/1982US Classes:514/376, Chalcogen bonded directly to ring carbon of the oxazole ring548/229Chalcogen bonded directly at 2-position of the oxazole ringExaminersPrimary: Gerstl, RobertAssistant: Gibson, S. A. Attorney, Agent or FirmInternational ClassesC07D 263/00 (20060101)C07C 205/11 (20060101) C07C 205/00 (20060101) C07D 263/20 (20060101) C07D 263/24 (20060101) Foreign Application Priority Data1981-02-25 FRAbstractDerivatives corresponding to the general formula: ##STR1## in which Ar represents a phenyl group; a phenyl group substituted by a halogen atom or by a trifluoromethyl group; or the (chloro-3 fluoro-4) phenyl group and n is either equal to zero or equal to 1 in which case X is a chain chosen from the following: --CH2 --CH2 --, --CH=CH--, --C.tbd.C--, --CH2 --O-- whose CH2 group is linked to Ar.These compounds are useful as medicaments more especially for the treatment of troubles of the central nervous system and senescence.Field of SearchChalcogen bonded directly at 2-position of the oxazole ring |
| ||||||||||||||
